Navigation Links
RVX-208 Exploratory Study Illustrates Early Potential for Alzheimer's Disease
Date:11/10/2008


First in class drug illustrates early signal of transport of key amyloid

marker from brain

TSX Exchange Symbol: RVX

CALGARY, Nov. 10 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that treatment with its lead drug RVX-208, a first in class ApoA-I/Prebeta-HDL elevating drug, in a post-hoc analysis from the Phase 1a clinical trial found that treatment with RVX-208 resulted in a positive trend on an important marker of cognitive function and Alzheimer's disease, Amyloid-beta40 is an important constituent of amyloid plaques in the brains of Alzheimer's patients. The analysis of the plasma markers for Alzheimer's disease was performed by Dr. D. Larry Sparks, Senior Scientist and Head of the Roberts Laboratory for Neurodegenerative Disease Research at Sun Health Research Institute in Sun City, Arizona.

The Phase 1a trial, a double-blind, dose-escalation, placebo-controlled trial enrolled 24 subjects in three separate dosing cohorts for a period of one week: 6 received placebo, and 6 received 2mg/kg per day, 6 received 3mg/kg per day and 6 received 8 mg/kg per day of RVX-208. Plasma levels of A-beta (A-beta40) were measured on day 1 and 7. A 12-14 percent increase in plasma A-beta40 levels was observed at the highest dose of RVX-208 after 7 days of dosing. Based on the study hypothesis these results trended towards significance versus placebo, even with the minimal number of study subjects.

Emerging evidence from large epidemiology studies such as the Harvard Women's Study, the Honolulu-Asia Aging Study and the Whitehall II study continue to build support for the relationship between poor HDL and ApoA-I levels and decreased cognitive function and Alzheimer's disease. Dr. Sparks's investigation of elective statin use and fractionated cholesterol levels in the ADAPT cohort has identified a significant relationship between elevated HDL levels and better performance on the Mini Mental State
'/>"/>

SOURCE Resverlogix Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. International Steering Committee for RVX-208 IVUS Trial Formed
2. Phase 1b/2a Program Commences for RVX-208
3. Industry Leaders Select Resverlogixs RVX-208
4. Dosing for RVX-208 Phase 1a Clinical Study Completed
5. FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208
6. Reverse Cholesterol Transport by RVX-208 a Small Molecule for ApoA-I Production Increase Presented at American Heart Association Scientific Meeting
7. deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke
8. Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Cortheras Relaxin in Acute Heart Failure
9. Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated
10. New Study Shares Best Practices in Biopharma Public Relations
11. Study From the University of Texas M.D. Anderson Cancer Center Demonstrates That AHCC(R) is Safe in Combination With Most Chemotherapeutic Agents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Pittcon is pleased to announce that the 2015 ... Scientific, have organized a session on nanotechnology for presentation ... Asia’s largest analytical and scientific instruments show, will be ... , The four speakers in this U.S. symposium, “Thinking ... Single Cells” will present their use of nanotechnology to ...
(Date:8/29/2014)... Hills, NY (PRWEB) August 29, 2014 ... Burnt Hills Veterinary Hospital are seeking candidates to participate ... dogs with osteoarthritis. The ultimate goal of this ... donor stem cells into one or two arthritically affected ... treated joints. , Candidates for the current investigational ...
(Date:8/29/2014)... August 29, 2014 Due to a misstatement ... week, the Adult Stem Cell Technology Center, LLC ( ASCTC ... stem cell therapy research that might benefit ALS patients. ... for new stem cell technologies and therapeutic applications, FRC listed ... Bucket Challenge donors who wish not to support research ...
(Date:8/29/2014)... Boston, MA, San Antonio, TX (PRWEB) August 29, ... audited, ISO 9001:2008 and ISO 13485:2003 certified, GAMP® ... it has been awarded an international Phase II ... patients with non-Hodgkin’s lymphoma. , Throughout this trial, ... services including, but not limited to, protocol and ...
Breaking Biology Technology:Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2
... May 14 StemCor Systems, Inc., a,medical device ... today that it has been awarded a,National Institutes ... Grant entitled "Adult Stem Cell Minimally Invasive Bone ... MarrowMiner(TM) which,recently received 510(k) clearance from the U.S. ...
... 2008 - A team of five University of Akron ... role of temperature and humidity in PLoS ONE, an ... , The UA authors are Dr. Peter Niewiarowski, professor ... Ge, graduate assistant in polymer science; Emily Hagan (undergraduate ...
... Flow Cytometry Platforms, FRANKLIN LAKES, N.J., May 13 ... announced today that it has acquired all,of the outstanding ... Seattle that develops and markets advanced flow,cytometry cell sorting ... disclosed. The acquisition,is not expected to have a material ...
Cached Biology Technology:StemCor Systems, Inc. Awarded NIH SBIR Grant for Bone Marrow Aspiration Platform 2StemCor Systems, Inc. Awarded NIH SBIR Grant for Bone Marrow Aspiration Platform 3BD Announces Acquisition of Cytopeia 2BD Announces Acquisition of Cytopeia 3
(Date:8/31/2014)... Warwick have discovered that ,good, cholesterol is turned ,bad, ... - MG, was found to damage ,good, HDL cholesterol, ... body. , Low levels of HDL, High Density ... levels of MG being common in the elderly and ... by funding from the British Heart Foundation (BHF) and ...
(Date:8/31/2014)... busy attacking us, germs go after each other. But ... for the infected microbes: Sometimes viruses actually carry helpful ... its diet or better attack its own hosts. , ... system would robotically destroy anything it recognized as invading ... now revealed that one variety of the bacterial immune ...
(Date:8/31/2014)... French . Montral, ... prestigious Nature Neuroscience journal by, Sylvain Williams, PhD, ... Mental Health University Institute and McGill University, opens the door ... controlling memory as well of the role of an essential ... , In 2009, they developed a unique approach ...
Breaking Biology News(10 mins):Sugar substance 'kills' good HDL cholesterol, new research finds 2Discovery reveals how bacteria distinguish harmful vs. helpful viruses 2Discovery reveals how bacteria distinguish harmful vs. helpful viruses 3Memory and Alzheimer's: Towards a better comprehension of the dynamic mechanisms 2
... can greatly impact biological species and ecosystems, requiring ... accommodate habitat shifts. Recorded data already show ... regions where their climatic requirements are better met. ... regulators on climate change implications for local conservation, ...
... continue to be energy-intensive and highly polluting for the foreseeable ... the agenda, according to a study published in the ... Xia of Dongbei University of Finance and Economics and the ... has looked at almost a decade,s worth of data from ...
... in the Department of Chemistry and Biochemistry at the ... Career Development Award from the National Science Foundation (NSF) ... to study the biophysics of model cell membranes, with ... will support the purchase of a computer cluster for ...
Cached Biology News:Workshop to focus on conservation management and climate change 2Polluting China for the sake of economic growth 2Patel recognized with NSF Career Award for computer-modeling research on cell membranes 2Patel recognized with NSF Career Award for computer-modeling research on cell membranes 3
EnzChek Ultra Xylanase Assay Kit *500 assays*...
Goat polyclonal to p27 KIP 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-KRPATDDS STQNK, corresponding to Internal sequence amino acids 153-165 of Human p27 KIP 1 ...
Defender against cell death 1...
Wnt-1 (G-19)...
Biology Products: